New patent expiration for Novartis drug UTIBRON

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for UTIBRON
Annual Drug Patent Expirations for UTIBRON

Utibron is a drug marketed by Novartis and is included in one NDA. There are thirteen patents protecting this drug.

Drug patent litigation for UTIBRON.

This drug has three hundred and forty-two patent family members in forty-four countries.

The generic ingredient in UTIBRON is glycopyrrolate; indacaterol maleate. Additional details are available on the glycopyrrolate; indacaterol maleate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top